Sunday, June 28, 2015
Opdivo/Nivo approved as firstline treatment in EU!
How wonderful is that??!! According to the article Opdivo has been given a rapid approval for use in previously treated melanoma patients AND as a first line therapy! The article goes on to describe various studies demonstrating the benefits and side effects of anti-PD1(Opdivo in particular). Stuff we already know as many of us were ratties in the fun and games. I can only assume that given this status, Opdivo is being covered by European payor sources. NOW! What the heck is going on here in the US? Hopefully, the tide will turn here very soon as well and we will all see anti-PD1 as a covered first-line treatment option!
Fingers crossed! -c